329 related articles for article (PubMed ID: 16522150)
21. INVITOX 2004: 13th Workshop of the European Society of Toxicology In Vitro, organised in cooperation with the Scandinavian Society for Cell Toxicology.
Kolman A
Altern Lab Anim; 2004 Dec; 32(6):625-9. PubMed ID: 15757500
[TBL] [Abstract][Full Text] [Related]
22. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
Prueitt RL; Beck BD
Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
[No Abstract] [Full Text] [Related]
23. The patchwork of toxicological research for pharmaceutical testing.
von Aulock S
ALTEX; 2010; 27(1):1. PubMed ID: 20397314
[No Abstract] [Full Text] [Related]
24. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
Vogel R
ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
[TBL] [Abstract][Full Text] [Related]
25. An assessment of some recommendations made concerning the OECD Health Effects Test Guidelines.
Auletta A
Altern Lab Anim; 2006 Feb; 34(1):109-10. PubMed ID: 16522153
[No Abstract] [Full Text] [Related]
26. The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.
Balls M; Amcoff P; Bremer S; Casati S; Coecke S; Clothier R; Combes R; Corvi R; Curren R; Eskes C; Fentem J; Gribaldo L; Halder M; Hartung T; Hoffmann S; Schectman L; Scott L; Spielmann H; Stokes W; Tice R; Wagner D; Zuang V;
Altern Lab Anim; 2006 Dec; 34(6):603-20. PubMed ID: 17266393
[No Abstract] [Full Text] [Related]
27. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
[TBL] [Abstract][Full Text] [Related]
28. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
Gibson JE
Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
[No Abstract] [Full Text] [Related]
29. Alternative methods for developmental toxicity testing.
Piersma AH
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
[TBL] [Abstract][Full Text] [Related]
30. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
Blaauboer BJ
Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
[TBL] [Abstract][Full Text] [Related]
31. Introduction of in vitro data into local irritation/corrosion testing strategies by means of SAR considerations: assessment of chemicals.
Gerner I; Schlede E
Toxicol Lett; 2002 Feb; 127(1-3):169-75. PubMed ID: 12052655
[TBL] [Abstract][Full Text] [Related]
32. Reproductive toxicity testing under the REACH system--time for a paradigm shift.
Combes R
Altern Lab Anim; 2007 Mar; 35(1):1-4. PubMed ID: 17411346
[No Abstract] [Full Text] [Related]
33. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
34. Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models.
Bremer S; Pellizzer C; Adler S; Paparella M; de Lange J
Altern Lab Anim; 2002 Dec; 30 Suppl 2():107-9. PubMed ID: 12513659
[TBL] [Abstract][Full Text] [Related]
35. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
36. ECVAM and pharmaceuticals.
Vanparys P
Altern Lab Anim; 2002 Dec; 30 Suppl 2():221-3. PubMed ID: 12513680
[TBL] [Abstract][Full Text] [Related]
37. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
38. Alternatives to animal testing: current status and future perspectives.
Liebsch M; Grune B; Seiler A; Butzke D; Oelgeschläger M; Pirow R; Adler S; Riebeling C; Luch A
Arch Toxicol; 2011 Aug; 85(8):841-58. PubMed ID: 21607681
[TBL] [Abstract][Full Text] [Related]
39. Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop.
Kinsner-Ovaskainen A; Akkan Z; Casati S; Coecke S; Corvi R; Dal Negro G; De Bruijn J; De Silva O; Gribaldo L; Griesinger C; Jaworska J; Kreysa J; Maxwell G; McNamee P; Price A; Prieto P; Schubert R; Tosti L; Worth A; Zuang V
Altern Lab Anim; 2009 Sep; 37(4):437-44. PubMed ID: 19807215
[TBL] [Abstract][Full Text] [Related]
40. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
Combes RD
Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
